Asia: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Patanjali Journey: Supreme Court's Expanding Scrutiny On Advertising Compliance For Cosmetics

India's healthcare and food sectors have recently undergone significant compliance changes, particularly in advertising.

India Healthcare

AP

AZB & Partners

61款创新医疗器械获批：2023年度中国医疗器械注册工作报告亮点解读

在前一篇文章《60余款创新药获批：2022-2023年度中国药品审评报告亮点解读》中，我们对2022-2023年度药品审评报告中所体现的我国近两年药品注册与监管

China Healthcare

HK

Han Kun Law Offices

Investment Trends In The Agricultural Industry (Video)

Global agricultural investment is increasingly shaped by concerns around food provenance, production systems and long-term security.

Australia Healthcare

FC

FTI Consulting

Ten Minefields: A Guide To Avoiding Pitfalls In Applying For Human Genetic Resources Projects In China

In recent years, China's regulatory framework for human genetic resources has matured. Regulatory authorities have issued and updated a series of legal documents...

China Healthcare

HK

Han Kun Law Offices

Overview: 2022-2023 China Drug & Medical Device Annual Report

China Healthcare

HK

Han Kun Law Offices

Top 10 Traps To Avoid: Navigating China's HGR Applications

China Healthcare

HK

Han Kun Law Offices

Legislative Leaps And Medicare Tweaks - Dissecting The Health Legislation Amendment (Improved Medicare Integrity And Other Measures) Bill 2025

Australia Healthcare

GC

Gilchrist Connell

观点 | 生命科学行业License-In/Out合同争议要点分析（二）：适应症变更、监管要求变更、合同变更或解除

China Healthcare

HK

Han Kun Law Offices

NMPA's Releases Draft Measures For Data Protection (Data Exclusivity)

China Healthcare

EI

Eagle IP

药企出海新热点：管线分拆"SON"模式的实践解读

China Healthcare

HK

Han Kun Law Offices

Insights Into China Biotech's New Approach: Spin-Off-NewCo Model

China Healthcare

HK

Han Kun Law Offices

汉坤 • 观点 | 细胞与基因治疗领域又一利好：研究者发起的临床研究（IIT）管理办法正式落地

China Healthcare

HK

Han Kun Law Offices

汉坤 • 观点 | 解读2024年版《赫尔辛基宣言》最新亮点 — 全球医学研究伦理准则系统性更新

China Healthcare

HK

Han Kun Law Offices

观点 | 《医疗器械管理法（草案）》十大亮点快评

China Healthcare

HK

Han Kun Law Offices

GST On TV Or Television: Latest Rates, HSN Code & Impact

V

Vakilsearch

Beyond Borders - Episode 10: What You Need To Know About Singapore Employment Law (Podcast)

Singapore Employment

LS

Lewis Silkin

劳动法新规解读系列①：《劳动争议司法解释（二）》重点条款

China Employment

AB

AnJie Broad Law Firm

GST On Pens, Papers & Stationery Items: Rates & HSN Codes

V

Vakilsearch

When Tariff Test Threaten Exports, India Looks Inward And Beyond

India International

LP

Legitpro Law

See more

Food and Drugs Law

Growing SE Asia CPG: Operational And Technology Unlocks Needed

Valued at between USD 300–400 billion and with a projected compound annual growth rate of 3-5% over the next five years, Southeast Asia's Consumer-Packaged Goods market presents one of the sector's best growth opportunities globally.

Worldwide Consumer

A

AlixPartners

The Patanjali Journey: Supreme Court's Expanding Scrutiny On Advertising Compliance For Cosmetics

India's healthcare and food sectors have recently undergone significant compliance changes, particularly in advertising.

India Healthcare

AP

AZB & Partners

61款创新医疗器械获批：2023年度中国医疗器械注册工作报告亮点解读

在前一篇文章《60余款创新药获批：2022-2023年度中国药品审评报告亮点解读》中，我们对2022-2023年度药品审评报告中所体现的我国近两年药品注册与监管

China Healthcare

HK

Han Kun Law Offices

Bridging The Gap Between Investors And Operators In Agriculture (Video)

Australia Real Estate

FC

FTI Consulting

How Investors And Operators Can Capitalise On The Agricultural Value Chain (Video)

Australia Real Estate

FC

FTI Consulting

The Four Key Drivers Shaping The Future Of Agriculture (Video)

Australia Real Estate

FC

FTI Consulting

The Role Of Agriculture In Investment Portfolios (Video)

Australia Real Estate

FC

FTI Consulting

Investment Trends In The Agricultural Industry (Video)

Australia Healthcare

FC

FTI Consulting

Spice Crackdown: FSSAI's October 2025 Manufacturing Sweep Explained

IL

IndiaLaw LLP

See more

Patents

Doing Business in Australia - Life Sciences

The importance of reaping commercial and social benefits of research is recognised by medical and business communities.

Australia Commercial

DP

DLA Piper Australia

Natco Pharma Obtains Compulsory Licence To Manufacture Bayer's Patented 'Naxavar' Anti-Cancer Drug

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

R

Rouse

Australia's changing patent law landscape

The patent law landscape for life science companies in Australia may change significantly in 2012 with new legislation.

Australia Healthcare

DP

DLA Piper Australia

Health Practitioner Registration - A New National Scheme

Australia Healthcare

DP

DLA Piper Australia

Combination Patents: Smith & Nephew v Wake Forest University Health Sciences

NR

Norton Rose Fulbright Australia

Enantiomer Patent Valid In Australia; Extension Of Term Provisions Clarified

SF

Spruson & Ferguson

Obtaining A Patent Extension Term For Drug Delivery Products Or Methods Used In Combination With A Drug

NR

Norton Rose Fulbright Australia

Lundbeck V Alphapharm

NR

Norton Rose Fulbright Australia

Pharmaceutical Extension In New Zealand? Watch This Space!

New Zealand Healthcare

SF

Spruson & Ferguson

See more

Healthcare

The Patanjali Journey: Supreme Court's Expanding Scrutiny On Advertising Compliance For Cosmetics

India's healthcare and food sectors have recently undergone significant compliance changes, particularly in advertising.

India Healthcare

AP

AZB & Partners

61款创新医疗器械获批：2023年度中国医疗器械注册工作报告亮点解读

在前一篇文章《60余款创新药获批：2022-2023年度中国药品审评报告亮点解读》中，我们对2022-2023年度药品审评报告中所体现的我国近两年药品注册与监管

China Healthcare

HK

Han Kun Law Offices

The Four Key Drivers Shaping The Future Of Agriculture (Video)

There are four critical drivers influencing agriculture's future: affordability, product performance, sustainability and health. These priorities often compete, creating tensions across the value chain.

Australia Real Estate

FC

FTI Consulting

Ten Minefields: A Guide To Avoiding Pitfalls In Applying For Human Genetic Resources Projects In China

China Healthcare

HK

Han Kun Law Offices

Overview: 2022-2023 China Drug & Medical Device Annual Report

China Healthcare

HK

Han Kun Law Offices

Top 10 Traps To Avoid: Navigating China's HGR Applications

China Healthcare

HK

Han Kun Law Offices

Legislative Leaps And Medicare Tweaks - Dissecting The Health Legislation Amendment (Improved Medicare Integrity And Other Measures) Bill 2025

Australia Healthcare

GC

Gilchrist Connell

观点 | 生命科学行业License-In/Out合同争议要点分析（二）：适应症变更、监管要求变更、合同变更或解除

China Healthcare

HK

Han Kun Law Offices

药企出海新热点：管线分拆"SON"模式的实践解读

China Healthcare

HK

Han Kun Law Offices

See more

Life Sciences, Biotechnology & Nanotechnology

Revision Of MRP Post GST 2.0 Reforms: MRP Labelling Norms For FMCG And Pharma Sectors

In response to the recent Goods and Services Tax (‘GST') 2.0 reforms, the government has issued important clarifications to guide stakeholders...

LS

Lakshmikumaran & Sridharan

61款创新医疗器械获批：2023年度中国医疗器械注册工作报告亮点解读

在前一篇文章《60余款创新药获批：2022-2023年度中国药品审评报告亮点解读》中，我们对2022-2023年度药品审评报告中所体现的我国近两年药品注册与监管

China Healthcare

HK

Han Kun Law Offices

Ten Minefields: A Guide To Avoiding Pitfalls In Applying For Human Genetic Resources Projects In China

In recent years, China's regulatory framework for human genetic resources has matured. Regulatory authorities have issued and updated a series of legal documents...

China Healthcare

HK

Han Kun Law Offices

Overview: 2022-2023 China Drug & Medical Device Annual Report

China Healthcare

HK

Han Kun Law Offices

Customs Recordation In India: Understanding The Limits Of Border Enforcement Of IPR

MC

MAHESHWARI & CO. Advocates & Legal Consultants

Top 10 Traps To Avoid: Navigating China's HGR Applications

China Healthcare

HK

Han Kun Law Offices

观点 | 生命科学行业License-In/Out合同争议要点分析（二）：适应症变更、监管要求变更、合同变更或解除

China Healthcare

HK

Han Kun Law Offices

药企出海新热点：管线分拆"SON"模式的实践解读

China Healthcare

HK

Han Kun Law Offices

Insights Into China Biotech's New Approach: Spin-Off-NewCo Model

China Healthcare

HK

Han Kun Law Offices

See more

Latest Videos

See more

Investment Trends In The Agricultural Industry (Video)

FC

FTI Consulting

FSSAI's New Rule: Quarterly Reports On Expired & Rejected Food! (Video)

IL

IndiaLaw LLP

Sidharrth Shankar | Indian Healthcare Sector In 2023 And Way Forward In 2024 (Video)

J

JSA

How To Export Cosmetics To Thailand (Video)

TG

Tilleke & Gibbins

India's Attractiveness And Opportunities In Healthcare (Video)

NP

Nexdigm Private Limited

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More